- Home
- ALM vs AVXL Comparison
ALM vs AVXL Comparison
Compare ALM & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALM
- AVXL
- Stock Information
- Founded
- ALM N/A
- AVXL 2004
- Country
- ALM Canada
- AVXL United States
- Employees
- ALM N/A
- AVXL N/A
- Industry
- ALM Other Metals and Minerals
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALM Basic Materials
- AVXL Health Care
- Exchange
- ALM Nasdaq
- AVXL Nasdaq
- Market Cap
- ALM 958.4M
- AVXL 956.7M
- IPO Year
- ALM N/A
- AVXL N/A
- Fundamental
- Price
- ALM $7.00
- AVXL $8.62
- Analyst Decision
- ALM Strong Buy
- AVXL Strong Buy
- Analyst Count
- ALM 2
- AVXL 3
- Target Price
- ALM $11.50
- AVXL $44.00
- AVG Volume (30 Days)
- ALM 3.6M
- AVXL 1.4M
- Earning Date
- ALM 11-20-2025
- AVXL 08-12-2025
- Dividend Yield
- ALM N/A
- AVXL N/A
- EPS Growth
- ALM N/A
- AVXL N/A
- EPS
- ALM N/A
- AVXL N/A
- Revenue
- ALM $20,657,545.00
- AVXL N/A
- Revenue This Year
- ALM $121.93
- AVXL N/A
- Revenue Next Year
- ALM $133.39
- AVXL N/A
- P/E Ratio
- ALM N/A
- AVXL N/A
- Revenue Growth
- ALM 9.87
- AVXL N/A
- 52 Week Low
- ALM $3.16
- AVXL $5.22
- 52 Week High
- ALM $10.68
- AVXL $14.44
- Technical
- Relative Strength Index (RSI)
- ALM 47.76
- AVXL 41.72
- Support Level
- ALM $7.31
- AVXL $8.41
- Resistance Level
- ALM $9.06
- AVXL $9.50
- Average True Range (ATR)
- ALM 0.88
- AVXL 0.53
- MACD
- ALM -0.21
- AVXL -0.03
- Stochastic Oscillator
- ALM 2.89
- AVXL 25.25
About ALM Almonty Industries Inc. Common Shares
Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.